L
4.59
-0.09 (-1.92%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | LENZ Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
1.7
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.67 |
|
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 2.76% |
| 机构持股比例 | 92.94% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Alpha Wave Global, Lp | 30 Jun 2026 | 3,612,211 |
| Versant Venture Management, Llc | 30 Jun 2026 | 2,656,888 |
| 72 Investment Holdings, Llc | 30 Jun 2026 | 1,017,751 |
| C Worldwide Group Holding A/S | 30 Jun 2026 | 700,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合